For decades, the pharmaceutical industry has discussed moving away from in vivo models in preclinical research. Now, it’s more than a conversation. The FDA’s roadmap for reducing animal testing, ...
Agile Defense today announced that it has been awarded a $100 million Other Transaction Authority (OTA) agreement through the ...